Literature DB >> 6435837

6-Keto-prostaglandin E1-stimulated bone resorption in organ culture.

F E Dewhirst.   

Abstract

Previous investigations have shown that prostaglandin E2 (PGE2), 13, 14-dihydro-PGE2, and prostacyclin (PGI2) are among the most potent prostaglandin stimulators of bone resorption. 6-Keto-prostaglandin F1 alpha (6-keto-PGF 1 alpha; also called 6-oxo-prostaglandin F1 alpha), a metabolite of PGI2 formed by spontaneous hydrolysis, has little bone resorptive or other biological activity. The present study demonstrated that another metabolite of PGI2, 6-keto-prostaglandin E1 (6-keto-PGE1; also called 6-oxo-prostaglandin E1), was active in stimulating bone resorption in fetal rat long bone organ culture. 6-Keto-PGE1 stimulated significant release of previously incorporated 45Ca over the concentration range of 10(-9) to 10(-5) M. The potency of 6-keto-PGE1 was one-twelfth that of PGE2. If 6-keto-PGE1 is formed by bone or adjacent tissues, or reaches bone through the circulation, it could significantly affect bone mineral metabolism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435837     DOI: 10.1007/bf02405349

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  33 in total

1.  Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit.

Authors:  H W Seyberth; W C Hubbard; O Oelz; B J Sweetman; J T Watson; J A Oates
Journal:  Prostaglandins       Date:  1977-08

2.  A new prostaglandin transformed from arachidonic acid in carrageenin-induced granuloma.

Authors:  W C Chang; S Murota; M Matsuo; S Tsurufuji
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

3.  Effect of prostaglaidin endoperoxides and metabolites on bone resorption in vitro.

Authors:  L G Raisz; J W Dietrich; H A Simmons; H W Seyberth; W Hubbard; J A Oates
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

4.  Cardiovascular responses to 6-keto-prostaglandin E1 in the dogs.

Authors:  J Van Dam; T M Fitzpatrick; L S Friedman; P W Ramwell; J C Rose; P A Kot
Journal:  Proc Soc Exp Biol Med       Date:  1981-01

5.  6-keto-PGE1 exhibits more potent bronchodilatory activity in the cat than its precursor, PGI2.

Authors:  E W Spannhake; J L Levin; A L Hyman; P J Kadowitz
Journal:  Prostaglandins       Date:  1981-02

6.  Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.

Authors:  J M Dayer; J Bréard; L Chess; S M Krane
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

7.  [Prostacyclin formation in human cancer tissue of the gastrointestinal tract (author's transl)].

Authors:  C Gisinger; H Sinzinger; A Ferlitsch; H Seyfried; W Feigl
Journal:  Wien Klin Wochenschr       Date:  1981-12-11       Impact factor: 1.704

8.  The effect of 6-keto-prostaglandin E1 on human lymphocyte cAMP levels.

Authors:  R Mastacchi; S Fadda; V Tomasi; O Barnabei
Journal:  Prostaglandins Med       Date:  1980-12

9.  Prostaglandins as mediators of bone resorption in renal and breast tumours.

Authors:  M Greaves; K J Ibbotson; D Atkins; T J Martin
Journal:  Clin Sci (Lond)       Date:  1980-03       Impact factor: 6.124

10.  Prostacyclin in prostatic cancer: a better marker than bone scan or serum acid phosphatase?

Authors:  O Khan; C N Hensby; G Williams
Journal:  Br J Urol       Date:  1982-02
View more
  1 in total

1.  Prostaglandin expression profile in hypoxic osteoblastic cells.

Authors:  Christina M Lee; Damian C Genetos; Alice Wong; Clare E Yellowley
Journal:  J Bone Miner Metab       Date:  2009-05-28       Impact factor: 2.626

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.